{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T15:13:58Z","timestamp":1794496438305,"version":"4.9.1"},"reference-count":90,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T00:00:00Z","timestamp":1721865600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Numerous observational studies have identified associations between both psoriasis (PsO) and psoriatic arthritis (PsA), and autoimmune diseases (AIDs); however, the causality of these associations remains undetermined.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a bidirectional two-sample Mendelian Randomization study to identify causal associations and directions between both PsO and PsA and AIDs, such as systemic lupus erythematosus (SLE), Crohn\u2019s disease (CD), ulcerative colitis (UC), multiple sclerosis (MS), uveitis, bullous pemphigoid (BP), Hashimoto\u2019s thyroiditis (HT), rheumatoid arthritis (RA), vitiligo, and ankylosing spondylitis (AS). The causal inferences were drawn by integrating results from four regression models: Inverse Variance Weighting (IVW), MR-Egger, Weighted Median, and Maximum Likelihood. Furthermore, we performed sensitivity analyses to confirm the reliability of our findings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The results showed that CD [IVW odds ratio (OR\n                      <jats:sub>IVW<\/jats:sub>\n                      ), 1.11; 95% confidence interval (CI), 1.06-1.17;\n                      <jats:italic>P<\/jats:italic>\n                      = 8.40E-06], vitiligo (OR\n                      <jats:sub>IVW<\/jats:sub>\n                      , 1.16; 95% CI, 1.05-1.28;\n                      <jats:italic>P<\/jats:italic>\n                      = 2.45E-03) were risk factors for PsO, while BP may reduce the incidence of PsO (OR\n                      <jats:sub>IVW<\/jats:sub>\n                      , 0.91; 95% CI, 0.87-0.96;\n                      <jats:italic>P<\/jats:italic>\n                      = 1.26E-04). CD (OR\n                      <jats:sub>IVW<\/jats:sub>\n                      , 1.07; 95% CI, 1.02-1.12;\n                      <jats:italic>P<\/jats:italic>\n                      = 0.01), HT (OR\n                      <jats:sub>IVW<\/jats:sub>\n                      , 1.23; 95% CI, 1.08-1.40;\n                      <jats:italic>P<\/jats:italic>\n                      = 1.43E-03), RA (OR\n                      <jats:sub>IVW<\/jats:sub>\n                      , 1.11; 95% CI, 1.02-1.21,\n                      <jats:italic>P<\/jats:italic>\n                      = 2.05E-02), AS (OR\n                      <jats:sub>IVW<\/jats:sub>\n                      , 2.18; 95% CI, 1.46-3.27;\n                      <jats:italic>P<\/jats:italic>\n                      = 1.55E-04), SLE (OR\n                      <jats:sub>IVW<\/jats:sub>\n                      , 1.04; 95% CI, 1.01-1.08;\n                      <jats:italic>P<\/jats:italic>\n                      = 1.07E-02) and vitiligo (OR\n                      <jats:sub>IVW<\/jats:sub>\n                      , 1.27; 95% CI, 1.14-1.42;\n                      <jats:italic>P<\/jats:italic>\n                      = 2.67E-05) were risk factors for PsA. Sensitivity analyses had validated the reliability of the results.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our study provides evidence for potential causal relationships between certain AIDs and both PsO and PsA. Specifically, CD and vitiligo may increase the risk of developing PsO, while CD, HT, SLE, RA, AS, and vitiligo may elevate the risk for PsA. Additionally, it is crucial to closely monitor the condition of PsO patients with specific AIDs, as they have a higher likelihood of developing PsA than those without AIDs. Moving forward, greater attention should be paid to PsA and further exploration of other PsO subtypes is warranted.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2024.1422626","type":"journal-article","created":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T00:45:48Z","timestamp":1721868348000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["Causal associations between both psoriasis and psoriatic arthritis and multiple autoimmune diseases: a bidirectional two-sample Mendelian randomization study"],"prefix":"10.3389","volume":"15","author":[{"given":"Kexin","family":"Duan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingrui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaomin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shujing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinsheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,7,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32549-6","article-title":"Psoriasis","volume":"397","author":"Griffiths","year":"2021","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","first-page":"m1590","DOI":"10.1136\/bmj.m1590","article-title":"National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study","volume":"369","author":"Parisi","year":"2020","journal-title":"Bmj"},{"key":"B3","volume-title":"Global report on psoriasis","author":"World Health","year":"2016"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2015.05.001","article-title":"Prevalence of undiagnosed psoriatic arthritis among psoriasis patients: Systematic review and meta-analysis","volume":"73","author":"Villani","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2018-000656","article-title":"Distinguishing rheumatoid arthritis from psoriatic arthritis","volume":"4","author":"Merola","year":"2018","journal-title":"RMD Open"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1505557","article-title":"Psoriatic arthritis","volume":"376","author":"Ritchlin","year":"2017","journal-title":"N Engl J Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20184347","article-title":"Risk factors for the development of psoriasis","volume":"20","author":"Kamiya","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.880201","article-title":"Epidemiology of psoriasis and comorbid diseases: A narrative review","volume":"13","author":"Bu","year":"2022","journal-title":"Front Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.04.033","article-title":"Chronologic order of appearance of immune-mediated inflammatory diseases relative to diagnosis of psoriasis","volume":"81","author":"Andersen","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"16738","DOI":"10.1038\/s41598-023-43778-4","article-title":"Risk of incident autoimmune diseases in patients with newly diagnosed psoriatic disease: a nationwide population-based study","volume":"13","author":"Jung","year":"2023","journal-title":"Sci Rep"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0032487","article-title":"Population based study of 12 autoimmune diseases in Sardinia, Italy: prevalence and comorbidity","volume":"7","author":"Sardu","year":"2012","journal-title":"PloS One"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12742","article-title":"Prevalence and incidence rates of cardiovascular, autoimmune, and other diseases in patients with psoriatic or psoriatic arthritis: a retrospective study using Clinical Practice Research Datalink","volume":"29","author":"Edson-Heredia","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwy280","article-title":"A future for observational epidemiology: clarity, credibility, transparency","volume":"188","author":"Harper","year":"2019","journal-title":"Am J Epidemiol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddu328","article-title":"Mendelian randomization: genetic anchors for causal inference in epidemiological studies","volume":"23","author":"Davey Smith","year":"2014","journal-title":"Hum Mol Genet"},{"key":"B15","doi-asserted-by":"publisher","first-page":"k601","DOI":"10.1136\/bmj.k601","article-title":"Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians","volume":"362","author":"Davies","year":"2018","journal-title":"Bmj"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.17219","article-title":"Mendelian randomization","volume":"318","author":"Emdin","year":"2017","journal-title":"Jama"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.xhgg.2021.100069","article-title":"Transethnic analysis of psoriasis susceptibility in South Asians and Europeans enhances fine-mapping in the MHC and genomewide","volume":"3","author":"Stuart","year":"2022","journal-title":"HGG Adv"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1002\/art.42154","article-title":"Comparative genetic analysis of psoriatic arthritis and psoriasis for the discovery of genetic risk factors and risk prediction modeling","volume":"74","author":"Soomro","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3680","article-title":"Genome-wide association studies of autoimmune vitiligo identify 23 new risk loci and highlight key pathways and regulatory variants","volume":"48","author":"Jin","year":"2016","journal-title":"Nat Genet"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btu779","article-title":"SNiPA: an interactive, genetic variant-centered annotation browser","volume":"31","author":"Arnold","year":"2015","journal-title":"Bioinformatics"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btz469","article-title":"PhenoScanner V2: an expanded tool for searching human genotype-phenotype associations","volume":"35","author":"Kamat","year":"2019","journal-title":"Bioinformatics"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1177\/0962280210394459","article-title":"Using multiple genetic variants as instrumental variables for modifiable risk factors","volume":"21","author":"Palmer","year":"2012","journal-title":"Stat Methods Med Res"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003288","article-title":"Genetics of height and risk of atrial fibrillation: A Mendelian randomization study","volume":"17","author":"Levin","year":"2020","journal-title":"PloS Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyz200","article-title":"Education protects against coronary heart disease and stroke independently of cognitive function: evidence from Mendelian randomization","volume":"48","author":"Gill","year":"2019","journal-title":"Int J Epidemiol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1002\/sim.6835","article-title":"Combining information on multiple instrumental variables in Mendelian randomization: comparison of allele score and summarized data methods","volume":"35","author":"Burgess","year":"2016","journal-title":"Stat Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression","volume":"44","author":"Bowden","year":"2015","journal-title":"Int J Epidemiol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1002\/gepi.21965","article-title":"Consistent estimation in mendelian randomization with some invalid instruments using a weighted median estimator","volume":"40","author":"Bowden","year":"2016","journal-title":"Genet Epidemiol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2021.05.014","article-title":"Constrained maximum likelihood-based Mendelian randomization robust to both correlated and uncorrelated pleiotropic effects","volume":"108","author":"Xue","year":"2021","journal-title":"Am J Hum Genet"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)31711-1","article-title":"Crohn\u2019s disease","volume":"389","author":"Torres","year":"2017","journal-title":"Lancet"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2018.3631","article-title":"Association of psoriasis with inflammatory bowel disease: A systematic review and meta-analysis","volume":"154","author":"Fu","year":"2018","journal-title":"JAMA Dermatol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-202143","article-title":"Psoriasis, psoriatic arthritis and increased risk of incident Crohn\u2019s disease in US women","volume":"72","author":"Li","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3390\/nu11040931","article-title":"Dietary factors in sulfur metabolism and pathogenesis of ulcerative colitis","volume":"11","author":"Teigen","year":"2019","journal-title":"Nutrients"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1002\/bies.201600008","article-title":"The gut-skin axis in health and disease: A paradigm with therapeutic implications","volume":"38","author":"O\u2019Neill","year":"2016","journal-title":"Bioessays"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-017-1750-3","article-title":"The role of microbiota, and probiotics and prebiotics in skin health","volume":"309","author":"Maguire","year":"2017","journal-title":"Arch Dermatol Res"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2016.01.001","article-title":"Mechanisms behind efficacy of tumor necrosis factor inhibitors in inflammatory bowel diseases","volume":"159","author":"Olesen","year":"2016","journal-title":"Pharmacol Ther"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2012-302853","article-title":"Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-\u03b3-expressing Th1 cells and IL-17A\/IL-22-expressing Th17 cells and respond to anti-IL-12\/IL-23 antibody treatment","volume":"63","author":"Tillack","year":"2014","journal-title":"Gut"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19010171","article-title":"Psoriasis: A STAT3-centric view","volume":"19","author":"Calautti","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2021.09.005","article-title":"ROR\u03b3t protein modifications and IL-17-mediated inflammation","volume":"42","author":"Kumar","year":"2021","journal-title":"Trends Immunol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2017.03.010","article-title":"Bullous pemphigoid","volume":"16","author":"Ba\u011fc\u0131","year":"2017","journal-title":"Autoimmun Rev"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2011.10386.x","article-title":"Comorbidity profiles among patients with bullous pemphigoid: a nationwide population-based study","volume":"165","author":"Chen","year":"2011","journal-title":"Br J Dermatol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2015.03.016","article-title":"Coexistence of autoimmune bullous diseases (AIBDs) and psoriasis: A series of 145 cases","volume":"73","author":"Ohata","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"B42","article-title":"Pemphigus associated with psoriasis vulgaris: A retrospective study of seven patients and a review of the literature","volume":"26","author":"Zhang","year":"2018","journal-title":"Acta Dermatovenerol Croat"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1684\/ejd.2016.2888","article-title":"Bullous pemphigoid during ustekinumab therapy in a psoriatic patient","volume":"27","author":"Onsun","year":"2017","journal-title":"Eur J Dermatol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.13909","article-title":"Development of bullous pemphigoid during secukinumab treatment for psoriasis","volume":"44","author":"Ho","year":"2017","journal-title":"J Dermatol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2018.00222","article-title":"Interaction of psoriasis and bullous diseases","volume":"5","author":"Dainichi","year":"2018","journal-title":"Front Med (Lausanne)"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1369\/0022155418782693","article-title":"Re-investigating the basement membrane zone of psoriatic epidermal lesions: is laminin-511 a new player in psoriasis pathogenesis","volume":"66","author":"Natsumi","year":"2018","journal-title":"J Histochem Cytochem"},{"key":"B47","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.coph.2018.12.007","article-title":"Pharmacological advances in pemphigoid","volume":"46","author":"Maglie","year":"2019","journal-title":"Curr Opin Pharmacol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1001\/jamadermatol.2021.1688","article-title":"Vitiligo","volume":"157","author":"LeWitt","year":"2021","journal-title":"JAMA Dermatol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S417290","article-title":"Psoriasis on lesions of vitiligo: A case report","volume":"16","author":"Wang","year":"2023","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2003.12.014","article-title":"Psoriasis and vitiligo","volume":"51","author":"Sandhu","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1159\/000354607","article-title":"Comorbidities associated with vitiligo: a ten-year retrospective study","volume":"227","author":"Sheth","year":"2013","journal-title":"Dermatology"},{"key":"B52","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s40257-018-0394-1","article-title":"Association between psoriasis and vitiligo: A systematic review and meta-analysis","volume":"20","author":"Yen","year":"2019","journal-title":"Am J Clin Dermatol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0023089","article-title":"Psoriasis regression analysis of MHC loci identifies shared genetic variants with vitiligo","volume":"6","author":"Zhu","year":"2011","journal-title":"PloS One"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2012.1117","article-title":"CD8+ T cells from vitiligo perilesional margins induce autologous melanocyte apoptosis","volume":"7","author":"Wu","year":"2013","journal-title":"Mol Med Rep"},{"key":"B55","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.autrev.2016.01.004","article-title":"The role of IL-17 in vitiligo: A review","volume":"15","author":"Singh","year":"2016","journal-title":"Autoimmun Rev"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-148X.2011.00945.x","article-title":"Dysregulation of melanocyte function by Th17-related cytokines: significance of Th17 cell infiltration in autoimmune vitiligo vulgaris","volume":"25","author":"Kotobuki","year":"2012","journal-title":"Pigment Cell Melanoma Res"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1111\/exd.12369","article-title":"T helper 17 and Tregs: a novel proposed mechanism for NB-UVB in vitiligo","volume":"23","author":"Hegazy","year":"2014","journal-title":"Exp Dermatol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"101367","DOI":"10.1016\/j.beem.2019.101367","article-title":"Hashimotos\u2019 thyroiditis: Epidemiology, pathogenesis, clinic and therapy","volume":"33","author":"Ragusa","year":"2019","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-017-8900-8","article-title":"Increased incidence of autoimmune thyroid disorders in patients with psoriatic arthritis: a longitudinal follow-up study","volume":"65","author":"Fallahi","year":"2017","journal-title":"Immunol Res"},{"key":"B60","article-title":"High prevalence of thyroid autoimmunity and hypothyroidism in patients with psoriatic arthritis","volume":"33","author":"Antonelli","year":"2006","journal-title":"J Rheumatol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1007\/BF02231775","article-title":"Thyroid involvement in chronic inflammatory rheumatological disorders","volume":"12","author":"Bianchi","year":"1993","journal-title":"Clin Rheumatol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2014.10.016","article-title":"Autoimmune thyroid disorders","volume":"14","author":"Antonelli","year":"2015","journal-title":"Autoimmun Rev"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1080\/08916930802170401","article-title":"High values of alpha (CXCL10) and beta (CCL2) circulating chemokines in patients with psoriatic arthritis, in presence or absence of autoimmune thyroiditis","volume":"41","author":"Antonelli","year":"2008","journal-title":"Autoimmunity"},{"key":"B64","doi-asserted-by":"publisher","first-page":"R107","DOI":"10.1186\/ar1997","article-title":"Coexpression and interaction of CXCL10 and CD26 in mesenchymal cells by synergising inflammatory cytokines: CXCL8 and CXCL10 are discriminative markers for autoimmune arthropathies","volume":"8","author":"Proost","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.173.4.2815","article-title":"Characterization and recruitment of plasmacytoid dendritic cells in synovial fluid and tissue of patients with chronic inflammatory arthritis","volume":"173","author":"Lande","year":"2004","journal-title":"J Immunol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"Itc81","DOI":"10.7326\/AITC202006020","article-title":"Systemic lupus erythematosus","volume":"172","author":"Kiriakidou","year":"2020","journal-title":"Ann Intern Med"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.190940","article-title":"Increased prevalence of systemic lupus erythematosus comorbidity in patients with psoriatic arthritis: A population-based case-control study","volume":"48","author":"Korkus","year":"2021","journal-title":"J Rheumatol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clim.2014.05.004","article-title":"Emerging role of IL-17 and Th17 cells in systemic lupus erythematosus","volume":"154","author":"Martin","year":"2014","journal-title":"Clin Immunol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"20651","DOI":"10.1038\/srep20651","article-title":"A pathogenic IFN\u03b1, BLyS and IL-17 axis in Systemic Lupus Erythematosus patients","volume":"6","author":"L\u00f3pez","year":"2016","journal-title":"Sci Rep"},{"key":"B70","doi-asserted-by":"crossref","first-page":"482","DOI":"10.3892\/etm.2023.12181","article-title":"Molecular consideration relevant to the mechanism of the comorbidity between psoriasis and systemic lupus erythematosus (Review)","volume":"26","author":"Qu","year":"2023","journal-title":"Exp Ther Med"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2017-000215.110","article-title":"110 Successful treatment of refractory lupus nephritis with secukinumab in a patient complicated with psoriasis vulgaris","volume":"4","author":"Yoshinari","year":"2017","journal-title":"Lupus Sci Med"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1406182","article-title":"Ankylosing spondylitis and axial spondyloarthritis","volume":"374","author":"Taurog","year":"2016","journal-title":"N Engl J Med"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"365","author":"McInnes","year":"2011","journal-title":"N Engl J Med"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)30830-4","article-title":"The pathogenesis of psoriatic arthritis","volume":"391","author":"Veale","year":"2018","journal-title":"Lancet"},{"key":"B75","doi-asserted-by":"publisher","first-page":"101520","DOI":"10.1016\/j.smim.2021.101520","article-title":"Unexpected connections of the IL-23\/IL-17 and IL-4\/IL-13 cytokine axes in inflammatory arthritis and enthesitis","volume":"58","author":"Bridgewood","year":"2021","journal-title":"Semin Immunol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-205253","article-title":"The epidemiology of extra-articular manifestations in ankylosing spondylitis: a population-based matched cohort study","volume":"74","author":"Stolwijk","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-018-0006-8","article-title":"Axial disease in psoriatic arthritis and ankylosing spondylitis: a critical comparison","volume":"14","author":"Feld","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1097\/bor.0000000000000136","article-title":"What have we learned about genetic susceptibility in psoriasis and psoriatic arthritis","volume":"27","author":"Eder","year":"2015","journal-title":"Curr Opin Rheumatol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-857X(05)70045-4","article-title":"Genes in the spondyloarthropathies","volume":"24","author":"Wordsworth","year":"1998","journal-title":"Rheum Dis Clin North Am"},{"key":"B80","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nrrheum.2015.133","article-title":"Genetics of ankylosing spondylitis\u2013insights into pathogenesis","volume":"12","author":"Brown","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.2147\/TCRM","article-title":"Secukinumab for ankylosing spondylitis and psoriatic arthritis","volume":"12","author":"Lubrano","year":"2016","journal-title":"Ther Clin Risk Manag"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1002\/art.27334","article-title":"LY2439821, a humanized anti-interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I randomized, double-blind, placebo-controlled, proof-of-concept study","volume":"62","author":"Genovese","year":"2010","journal-title":"Arthritis Rheum"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209334","article-title":"Physical trauma recorded in primary care is associated with the onset of psoriatic arthritis among patients with psoriasis","volume":"76","author":"Thorarensen","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1002\/art.22758","article-title":"The concept of a \u201csynovio-entheseal complex\u201d and its implications for understanding joint inflammation and damage in psoriatic arthritis and beyond","volume":"56","author":"McGonagle","year":"2007","journal-title":"Arthritis Rheum"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2230.2001.00792.x","article-title":"Pathogenesis of psoriatic arthritis","volume":"26","author":"Fearon","year":"2001","journal-title":"Clin Exp Dermatol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2016.10.007","article-title":"The eye and inflammatory rheumatic diseases: The eye and rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis","volume":"30","author":"Murray","year":"2016","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2010.10.032","article-title":"Ocular psoriasis","volume":"65","author":"Rehal","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"B88","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1007\/s10067-015-2960-8","article-title":"Uveitis in spondyloarthritis including psoriatic arthritis, ankylosing spondylitis, and inflammatory bowel disease","volume":"34","author":"Rosenbaum","year":"2015","journal-title":"Clin Rheumatol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.19060","article-title":"Risk of uveitis in patients with psoriasis in Korea: A nationwide population-based cohort study","volume":"37","author":"Kim","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1038\/JID.2015.350","article-title":"Risk of multiple sclerosis in patients with psoriasis: A danish nationwide cohort study","volume":"136","author":"Egeberg","year":"2016","journal-title":"J Invest Dermatol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1422626\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T00:45:53Z","timestamp":1721868353000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1422626\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,25]]},"references-count":90,"alternative-id":["10.3389\/fimmu.2024.1422626"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1422626","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fimmu.2024.1422626.s001","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fimmu.2024.1422626.s002","asserted-by":"subject"}]},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,25]]},"article-number":"1422626"}}